1. Home
  2. PODD vs PHM Comparison

PODD vs PHM Comparison

Compare PODD & PHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • PHM
  • Stock Information
  • Founded
  • PODD 2000
  • PHM 1950
  • Country
  • PODD United States
  • PHM United States
  • Employees
  • PODD N/A
  • PHM N/A
  • Industry
  • PODD Medical/Dental Instruments
  • PHM Homebuilding
  • Sector
  • PODD Health Care
  • PHM Consumer Discretionary
  • Exchange
  • PODD Nasdaq
  • PHM Nasdaq
  • Market Cap
  • PODD 23.8B
  • PHM 27.0B
  • IPO Year
  • PODD 2007
  • PHM N/A
  • Fundamental
  • Price
  • PODD $317.83
  • PHM $127.60
  • Analyst Decision
  • PODD Strong Buy
  • PHM Buy
  • Analyst Count
  • PODD 18
  • PHM 14
  • Target Price
  • PODD $337.06
  • PHM $136.86
  • AVG Volume (30 Days)
  • PODD 662.8K
  • PHM 2.0M
  • Earning Date
  • PODD 11-06-2025
  • PHM 10-21-2025
  • Dividend Yield
  • PODD N/A
  • PHM 0.68%
  • EPS Growth
  • PODD N/A
  • PHM 2.26
  • EPS
  • PODD 3.32
  • PHM 13.40
  • Revenue
  • PODD $2,359,500,000.00
  • PHM $17,694,541,000.00
  • Revenue This Year
  • PODD $29.13
  • PHM N/A
  • Revenue Next Year
  • PODD $18.13
  • PHM $0.11
  • P/E Ratio
  • PODD $94.90
  • PHM $9.67
  • Revenue Growth
  • PODD 26.00
  • PHM 5.04
  • 52 Week Low
  • PODD $225.37
  • PHM $88.07
  • 52 Week High
  • PODD $353.50
  • PHM $149.47
  • Technical
  • Relative Strength Index (RSI)
  • PODD 40.26
  • PHM 44.31
  • Support Level
  • PODD $306.03
  • PHM $130.15
  • Resistance Level
  • PODD $315.44
  • PHM $138.33
  • Average True Range (ATR)
  • PODD 8.58
  • PHM 3.30
  • MACD
  • PODD -1.93
  • PHM -0.75
  • Stochastic Oscillator
  • PODD 45.94
  • PHM 8.36

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About PHM PulteGroup Inc.

PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.

Share on Social Networks: